•   
  •   
  •   

Health & Fit Moderna Announces Vaccine Nearly 95% Effective

16:00  16 november  2020
16:00  16 november  2020 Source:   eatthis.com

Second coronavirus vaccine is 94.5% effective in clinical trial

  Second coronavirus vaccine is 94.5% effective in clinical trial US-based Moderna has got a deal to supply 100million doses to the US and potentially 160million to the European Union but the jab is not one of the six pre-ordered by British officials.Early results from the company's final stage of clinical trials bring another landmark success in the global race to end the pandemic after Pfizer's vaccine, which works the same way, was found to be 90 per cent effective. But there won't be any Moderna doses available in Europe until spring 2021, while the US will get it this year.

A new vaccine that protects against Covid-19 is nearly 95 % effective , early data from US company Moderna shows. Moderna says it is a "great day" and they plan to apply for approval to use the vaccine in the next few weeks. However, this is still early data and key questions remain unanswered.

* * * Moderna has just published the first headline efficacy data from its Phase 3 COVID-19 trials showing that its breakthrough mRNA COVID-19 vaccine , which is extremely similar to the Pfizer-BioNTech candidate, is 94.5% effective at preventing the virus, higher than Pfizer's 90%, and

The new vaccine from Moderna, the biotechnology company, is 94.5% effective against coronavirus, according to the company on Monday, making it the second vaccine to look promising enough to hit the market in America. Last week, Pfizer's vaccine was found to be more than 90% effective. "This is a pivotal moment in the development of our COVID-19 vaccine candidate," Moderna CEO Stephane Bancel said in a statement. "Since early January, we have chased this virus with the intent to protect as many people around the world as possible. All along, we have known that each day matters. This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease." Read on to hear when you might get yours, and to ensure your health and the health of others, don't miss these Sure Signs You've Already Had Coronavirus.

Moderna is set to ask the FDA to authorize its coronavirus vaccine, a key step before it can be given to more people

  Moderna is set to ask the FDA to authorize its coronavirus vaccine, a key step before it can be given to more people If the FDA authorizes Moderna's vaccine, people could start getting shots in December.The biotech company plans to file today for emergency use authorization with the US Food and Drug Administration, Moderna said in a statement, about a week after Pfizer and BioNTech asked the FDA to green light their vaccine. The company is also seeking approval from regulators in other countries.

Moderna Vaccine Found Highly Effective at Preventing Covid. Moderna said on Monday that new stability data showed its vaccine is stable at refrigerator temperatures Infections were accumulating so fast in the trial that Moderna ’s analysis ended up being based on 95 cases, the company said.

Another Covid vaccine breakthrough as Moderna reveals its jab is 94.5% effective - making it BETTER than Pfizer's (but the UK hasn't bought Moderna becomes the second firm to announce early results from a clinical trial, suggesting 94.5% effective . In a study of 30,000, 95 people tested

a person in a blue cup: scientist looking at ampoule with new medication, vaccination development © Provided by Eat This, Not That! scientist looking at ampoule with new medication, vaccination development

Dr. Fauci Calls the Result "As Good as it Gets"

Moderna, based in Cambridge, Mass, said it plans to apply for emergency use authorization with the Food and Drug Administration in "the coming weeks." The trial's goal was clear: "The Phase 3 COVE trial is a randomized, 1:1 placebo-controlled study testing mRNA-1273 at the 100 µg dose level in 30,000 participants in the U.S., ages 18 and older. The primary endpoint is the prevention of symptomatic COVID-19 disease. Key secondary endpoints include prevention of severe COVID-19 disease and prevention of infection by SARS-CoV-2."

"These are obviously very exciting results," said Dr. Anthony Fauci, the nation's top infectious disease doctor, said, according to CNN. "It's just as good as it gets—94.5% is truly outstanding."

10 Best Ways to Cut Your Diabetes Risk, According to Doctors

  10 Best Ways to Cut Your Diabetes Risk, According to Doctors With a few simple lifestyle changes, you can lower your chance of developing diabetes.

Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94 Investors were expecting Moderna 's vaccine to be highly effective after Pfizer It announced in August that it had reached a deal with the U.S. government to supply 100 million doses of its vaccine .

Moderna has said it expects to provide the US government, which helped to fund research into the vaccine , with 20 million doses by the end of the year. Unlike Pfizer, Moderna has released a detailed breakdown of its trial data. Of the 95 infections recorded to date, 15 of participants were aged over 65

Regarding the timetable, Fauci said of the Pfizer vaccine the following, which could also apply to Moderna: "What will happen is that," after the emergency authorization is approved, "at the end of November, the beginning of December, if that goes through—and again, I don't want to get ahead of the FDA, if they're going to dot all the I's and cross all the T's—but I believe with the impressive nature of the data that that should go through smoothly, that by the time we get into December, we'll be able to have doses available for people who are judged to be at the highest priority to get."

As for logistics, "about getting the supply chain intact with the cold requirements"—the vaccine needs to be shipped at a certain low temperature—"that's all been anticipated and part of Operation Warp Speed, particularly on the general, Gus Perna, the general from the army who has been responsible for making sure this goes smoothly. We anticipate, although they're all logistic challenges that it will be done successfully."

FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting

  FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.This time, the committee is reviewing a vaccine made by Cambridge, Massachusetts, biotech Moderna, with similar technology and results as the one it supported last week by Pfizer and its German collaborator, BioNTech.

Moderna said the information is being prepared for submission to the trial's independent data safety monitoring board, which will look at the results and make a recommendation. There are no vaccines that have gained global approval yet, although a handful, including Moderna 's, are in late-stage studies.

The target vaccine efficacy (VE) against COVID-19 for powering assumptions is 60% ( 95 % confidence interval to Moderna has completed manufacture of vaccine required to start the Phase 3 study. In addition, Moderna recently announced a collaboration with Catalent for large-scale, commercial

As for who gets these vaccines first, Fauci said: "What we have well-established in this country is that the ultimate decision of the distribution in priority, or it goes with the CDC, their advisory committee on immunization practices, traditionally over the years for other vaccines has been responsible for advising them as to the prioritization of the distribution."

Regular folks with no underlying conditions might have theirs by April.

"This milestone is only possible because of the hard work and sacrifices of so many," said Barcel. "I want to thank the thousands of participants in our Phase 1, Phase 2 and Phase 3 studies, and the staff at our clinical trial sites who have been on the front lines of the fight against the virus. They are an inspiration to us all."

RELATED: Unhealthiest Habits on the Planet, According to Doctors

How to Not Die During the Pandemic Until the Vaccine Comes

As for yourself, do everything you can to prevent getting—and spreading—COVID-19 in the first place until there's a vaccine available: Wear your face mask, get tested if you think you have coronavirus, avoid crowds (and bars, and house parties), practice social distancing, only run essential errands, wash your hands regularly, disinfect frequently touched surfaces, stay outdoors more than indoors, and to get through this pandemic at your healthiest, don't miss these 35 Places You're Most Likely to Catch COVID.

How Moderna's coronavirus vaccine differs from Pfizer's

  How Moderna's coronavirus vaccine differs from Pfizer's A second coronavirus vaccine could be made available in the U.S. as early as this week. The FDA is expected to authorize Moderna's vaccine for emergency use as cases skyrocket this holiday season. Dr. Leo Nissola is a medical expert and immunotherapy scientist. He joined CBSN to discuss the latest.

Want to get in shape? Here’s how to start! .
Getting in shape is a resolution or goal just about everyone has had at some point in their lives. With so much information on what to eat, drink, or do, it can get a bit overwhelming. So for those new to their fitness journey, here are some simple tips that can start you off on the right path.

usr: 2
This is interesting!